AR034703A1 - Metodos y composiciones para preparar emamectina. - Google Patents

Metodos y composiciones para preparar emamectina.

Info

Publication number
AR034703A1
AR034703A1 ARP020101764A ARP020101764A AR034703A1 AR 034703 A1 AR034703 A1 AR 034703A1 AR P020101764 A ARP020101764 A AR P020101764A AR P020101764 A ARP020101764 A AR P020101764A AR 034703 A1 AR034703 A1 AR 034703A1
Authority
AR
Argentina
Prior art keywords
monooxygenases
methods
prepare
avermectin
emamectine
Prior art date
Application number
ARP020101764A
Other languages
English (en)
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Publication of AR034703A1 publication Critical patent/AR034703A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe la familia de monooxigenasa P450, cada miembro de las cuales oxida regioselectivamente avermectina a 4''ceto-avermectina. Las monooxigenasas P450 encuentran uso en los métodos y formulaciones para preparar emamectina a partir de avermectina. Asimismo, se describen métodos para purificar las monooxigenasas P450 de la invención, los agentes adherentes que se deben específicamente a las monooxigenasas P450 de la invención, y células genéticamente manipuladas que expresan las monooxigenasas P450 de la invención. Asimismo se describen ferrodoxinas y ferrodoxinas reductasas que son activas con las monooxigenasas P450 .
ARP020101764A 2001-05-16 2002-05-14 Metodos y composiciones para preparar emamectina. AR034703A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29114901P 2001-05-16 2001-05-16

Publications (1)

Publication Number Publication Date
AR034703A1 true AR034703A1 (es) 2004-03-17

Family

ID=23119055

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101764A AR034703A1 (es) 2001-05-16 2002-05-14 Metodos y composiciones para preparar emamectina.

Country Status (17)

Country Link
US (1) US20030068788A1 (es)
EP (1) EP1389239A2 (es)
JP (1) JP2004529651A (es)
KR (1) KR20040005963A (es)
CN (1) CN1514880A (es)
AR (1) AR034703A1 (es)
AU (1) AU2002342337B2 (es)
BR (1) BR0209813A (es)
CA (1) CA2446130A1 (es)
CZ (1) CZ20033078A3 (es)
HU (1) HUP0400008A2 (es)
IL (1) IL158764A0 (es)
MX (1) MXPA03010381A (es)
PL (1) PL367195A1 (es)
RU (1) RU2003135646A (es)
WO (1) WO2002092801A2 (es)
ZA (1) ZA200307737B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4251554B2 (ja) * 2002-04-12 2009-04-08 メルシャン株式会社 大腸菌における放線菌由来チトクロームｐ−４５０遺伝子の発現系
CA2546614A1 (en) 2003-11-27 2005-06-09 Mercian Corporation Dna participating in hydroxylation of macrolide compound
WO2006009276A1 (ja) 2004-07-20 2006-01-26 Eisai R & D Management Co., Ltd. プラジエノライドの生合成に関与するポリペプチドをコードするｄｎａ
NZ548935A (en) * 2006-07-06 2007-03-30 Wyeth Corp Biocatalytic oxidation of LL-F28249-alpha
WO2008096695A1 (ja) * 2007-02-05 2008-08-14 Mercian Corporation ビタミンｄ類の水酸化に関連するdna
JP6410802B2 (ja) * 2013-09-19 2018-10-24 フイルメニツヒ ソシエテ アノニムＦｉｒｍｅｎｉｃｈ Ｓａ 芳香性アルコールの製造方法
JP6522551B2 (ja) 2016-06-10 2019-05-29 長谷川香料株式会社 （−）−ロタンドンの製造方法
GB201807815D0 (en) 2018-05-14 2018-06-27 Hypha Discovery Ltd Hydroxylation techniques
GB201819209D0 (en) 2018-11-26 2019-01-09 Hypha Discovery Ltd Biocatalytic techniques
CN110305818A (zh) * 2019-08-15 2019-10-08 齐鲁制药（内蒙古）有限公司 一种阿维菌素菌种选育方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US4874749A (en) * 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
CA2125947A1 (en) * 1991-12-16 1993-06-24 Fateme Sima Sariaslani Constitutive expression of p450soy and ferredoxin-soy in streptomyces, and biotransformation of chemicals by recombinant organisms
US5399717A (en) * 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US6117659A (en) * 1997-04-30 2000-09-12 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
US6265202B1 (en) * 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
GB9926887D0 (en) * 1999-11-12 2000-01-12 Novartis Ag Organic compounds
JP2002058490A (ja) * 2000-08-22 2002-02-26 Kyowa Hakko Kogyo Co Ltd 新規チトクロームｐ４５０

Also Published As

Publication number Publication date
EP1389239A2 (en) 2004-02-18
MXPA03010381A (es) 2004-03-16
PL367195A1 (en) 2005-02-21
US20030068788A1 (en) 2003-04-10
JP2004529651A (ja) 2004-09-30
CZ20033078A3 (cs) 2004-02-18
RU2003135646A (ru) 2005-05-10
BR0209813A (pt) 2004-06-01
WO2002092801A2 (en) 2002-11-21
IL158764A0 (en) 2004-05-12
KR20040005963A (ko) 2004-01-16
ZA200307737B (en) 2004-04-21
HUP0400008A2 (hu) 2004-04-28
CN1514880A (zh) 2004-07-21
CA2446130A1 (en) 2002-11-21
AU2002342337B2 (en) 2006-01-05
WO2002092801A3 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
TW200505411A (en) A formulation for chemical peeling
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
AR034703A1 (es) Metodos y composiciones para preparar emamectina.
MXPA02010971A (es) Poblaciones de espermatozoides que portan cromosoma x y que porta cromosoma y de alta pureza.
AU2003209259A8 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
EP1709195A4 (en) CELLULAR TRANSFECTION FORMULATIONS OF SMALL INTERFERING RNA, COMPOSITIONS THEREFOR, AND METHODS OF PRODUCTION AND USE
AU2001282399A1 (en) Resorcinol derivatives
CA2420874A1 (en) Active ingredient combinations with insecticidal and acaricidal properties
ATE353641T1 (de) Benzamide als kaliumkanal-inhibitoren
HUP0303621A2 (hu) Hasmenéscsökkentő ágenst és epotilont vagy epotilonszármazékot tartalmazó kombinációkat tartalmazó gyógyszerkészítmények
WO2005000248A3 (en) Compositions and methods for skin conditioning
MXPA05012319A (es) Suministro de compuestos con celulas sanguineas rehidratadas.
BR0109780A (pt) Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas
WO2004064737A3 (en) Therapeutics compositions
DK1066291T3 (da) Svampedræbende 6-(2-halogen-4-alkoxyphenyl)-triazolopyrimidiner
DK1330258T3 (da) Kahalalid F-formulering
ATE345349T1 (de) Purinderivate
TR200102742T2 (tr) Rezorsinol türevleri
ITMI20011762A0 (it) Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione
SG161309A1 (en) Hair tonic
ATE473730T1 (de) Verwendung von 3-positions-cyclosporin-derivaten für haarwachstum
ATE404602T1 (de) Wässrige polyurethanzubereitungen
RS20060154A (en) Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
EP1560558A4 (en) USE OF CYCLOSPORINE DERIVATIVES IN POSITION 3 FOR CAPILLARY GROWTH

Legal Events

Date Code Title Description
FB Suspension of granting procedure